Phase 4 Trial Finds Tudorza Safe and Effective for COPD Patients with Cardiovascular Disease – COPD News Today


COPD News Today

Phase 4 Trial Finds Tudorza Safe and Effective for COPD Patients with Cardiovascular Disease
COPD News Today
Tudorza, developed by AstraZeneca, contains the long-acting muscarinic antagonist (LAMA) aclidinium bromide, a bronchodilator that helps to open the airways to make it easier to breathe. In the United States, Tudorza is marketed by Circassia ...